UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549

 

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934
(Amendment No. 4)*

 

(Name of Issuer)

 

(Title of Class of Securities)

 

(CUSIP Number)

 

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

2

 

 

 

3

 

 

 

4

 

 

 

5

 

This Amendment No. 4 to the Statement on Schedule 13D amends and supplements Items 2, 3, 4, 5, 6 and 7 of the Statement on Schedule 13D originally filed with the Securities and Exchange Commission on October 31, 2008 (as amended from time to time, the “Schedule 13D”), and relates to the shares of common stock, par value $0.10 per share (“Issuer Common Stock”), of X-Rite, Incorporated, a Michigan corporation (“X-Rite” or the “Issuer”).  Each item below amends and supplements the information disclosed under the corresponding item of the Schedule 13D. Capitalized terms defined in the Schedule 13D are used herein with their defined meanings.

 

Item 2.                    Identity and Background

 

Item 2 of the Schedule 13D is hereby amended by replacing Schedule I with Schedule I hereto.

 

Item 3.                    Source and Amount of Funds or Other Consideration

 

Item 3 of the Schedule 13D is hereby amended and restated in its entirety by incorporating the information set forth in Items 4 and 6 hereof by reference into this Item 3.

 

Item 4.                    Purpose of the Transaction.

 

Item 4 of the Schedule 13D is hereby amended and supplemented with the addition of the following, immediately following the third paragraph:

 

On April 10, 2012, the Issuer entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among Danaher Corporation, a Delaware corporation (“Parent”), Termessos Acquisition Corp., a Michigan corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and the Issuer, pursuant to which, among other things, Merger Sub agreed to make a cash tender offer (the “Tender Offer”) to acquire all of the Issuer’s outstanding Issuer Common Stock at a purchase price of $5.55 per share, and, following completion of such Tender Offer, Merger Sub will be merged with and into the Issuer (the “Merger”) with the issuer surviving the Merger as the wholly owned subsidiary of Parent, in each case on the terms and subject to the conditions set forth in the Merger Agreement.  At the effective time of the Merger (the “Effective Time”), all remaining outstanding shares of Issuer Common Stock not tendered in the Tender Offer will be acquired for cash at $5.55 per share, on the terms and conditions set forth in the Merger Agreement.  For a more detailed description of the Merger Agreement, please see the Current Report on Form 8-K filed by the Issuer on April 11, 2012.

 

In connection with the entry into the Merger Agreement by the parties thereto, OEP entered into a Tender and Support Agreement with Parent and Merger Sub, (the “Support Agreement”). The Support Agreement provides that OEP shall, among other things: (a) tender 19,711,630 shares of Issuer Common Stock beneficially owned by OEP (the “Subject Shares”) to Merger Sub; (b) vote all Subject Shares (i) in favor of the approval and adoption of the Merger Agreement and the transactions contemplated thereunder, and (ii) against (A) any action or agreement which would in any material respect impede, interfere with or prevent the Tender Offer or the Merger, (B) any Alternative Proposal (as defined in the Merger Agreement) or (C) any action, proposal, transaction or agreement that would reasonably be expected to result in the occurrence of any condition set forth in Annex I to the Merger Agreement or result in any breach of any covenant, representation or warranty or any other obligation or agreement of OEP under

 

6

 

the Support Agreement; (c) not transfer, sell, assign, gift, hedge, pledge or otherwise dispose of any shares of Issuer Common Stock or any right or interest therein or enter into any contract, option or other agreement, arrangement or understanding with respect to any such transfer of, Subject Shares or any right or interest therein; (d) not grant any proxy, power-of-attorney or other authorization with respect to the Subject Shares; and (e) not take or permit any other actions that would in any way restrict, limit or interfere with the performance of OEP’s obligations under the Support Agreement.

 

In addition, pursuant to the Support Agreement, OEP has agreed: (i) not to commence or join in, and agreed to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Issuer or any of their respective successors (x) challenging the validity of, or seeking to enjoin the operation of, any provision of the Support Agreement or (y) alleging breach of any fiduciary duty of any person in connection with the negotiation and entry into the Merger Agreement; and (ii) prior to the Acceptance Time (as defined in the Merger Agreement), to enter into irrevocable agreements to terminate the Key Stockholder Agreements (as defined in the Merger Agreement) to which it is a party, which termination shall be conditioned solely upon the occurrence of the closing of the Merger.

 

Pursuant to the Support Agreement, OEP also agreed (A) not to, and not to authorize or permit any of its representatives to, directly or indirectly: (i) initiate, solicit, propose, knowingly encourage or knowingly facilitate the making of any proposal or offer that constitutes, or could reasonably be expected to lead to, an Alternative Proposal; (ii) enter into any agreement with respect to any Alternative Proposal; (iii) engage in, continue or otherwise participate in any discussions or negotiations regarding, or provide any information or data concerning the Issuer or any of its subsidiaries to any person relating to, any Alternative Proposal  or any proposal or offer that could reasonably be expected to lead to an Alternative Proposal; or (iv) tender any Subject Shares in connection with an Alternative Proposal; and (B) to, and cause its representatives to, immediately cease all discussions and negotiations with any person that may be ongoing with respect to any proposal that constitutes, or is reasonably expected to lead to, any Alternative Proposal.

 

The Support Agreement does not limit or otherwise affect the actions of OEP or any affiliate, employee or designee of OEP or any of its affiliates in its capacity, if applicable, as an officer or director of the Issuer.

 

The Support Agreement will automatically terminate upon the first to occur of: (i) the termination of the Merger Agreement in accordance with its terms; (ii) the Effective Time; (iii) the Tender Offer shall have terminated or the Expiration Date (as defined in the Merger Agreement) shall have occurred, in each case without acceptance for payment of the Subject Shares pursuant to the Tender Offer; (iv) the date of any material modification, waiver or amendment to any provision of the Merger Agreement or the terms of the Tender Offer that reduces the amount, changes the form or otherwise adversely affects the consideration payable to OEP pursuant to the Merger Agreement as in effect as of the date of the Support Agreement; (v) any amendment, modification or waiver of the Minimum Condition (as defined in the Merger Agreement) such that Parent or Merger Sub would beneficially own less than a majority of the of the Issuer Common Stock then outstanding on a fully diluted basis after giving effect to the consummation of the Tender Offer; and (vi) the mutual written consent of the parties to the Support Agreement.

 

7

 

The foregoing description of the Support Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Support Agreement, a form of which is filed as Exhibit 10 hereto.

 

It is the present intention of OEP to tender in the Tender Offer all of the Issuer Common Stock held by OEP (or its affiliates) and, if applicable, vote or cause to be voted all such shares of Issuer Common Stock in favor of the approval and adoption of the Merger Agreement and the transactions contemplated thereby, assuming compliance in each case with the terms and conditions of the Merger Agreement.  The Reporting Persons may, at any time, review and reconsider this intention and reserve the right to change this position with respect to all or a portion of such shares, subject to those terms of the Support Agreement which restrict tendering and voting the Subject Shares.

 

Item 5.                    Interest in Securities of the Issuer.

 

Item 5 of the Schedule 13D is hereby amended and restated in its entirety by the following:

 

(a) and (b) The information contained on the cover pages to this Schedule 13D and the information set forth or incorporated in Items 2, 3, 4 and 6 hereof are incorporated herein by reference.

 

(c) None of the Reporting Persons has engaged in any transactions during the past 60 days in, any shares of Issuer Common Stock, except as described in this Schedule 13D.

 

(d) Not applicable.

 

(e) Not applicable.

 

Item 6.                    Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

The response set forth in Item 6 of this Schedule 13D is hereby amended by adding the information contained in Item 4 hereof, which is incorporated by reference.

 

Item 7.                    Materials to be Filed as Exhibits.

 

Number		Exhibit
10		Tender and Support Agreement, dated as of April 10, 2012, by and among Danaher Corporation, Termessos Acquisition Corp., and OEP

 

8

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

OEPX, LLC
	By:	/s/ Colin M. Farmer
	Name: Colin M. Farmer
	Title: President
ONE EQUITY PARTNERS III, L.P.
	By:	OEP General Partner III, L.P.
		as its general partner
	By:	OEP Parent LLC
		as its general partner
		By:		/s/ Colin M. Farmer
		Name: Colin M. Farmer
		Title: Managing Director
OEP GENERAL PARTNER III, L.P.
	By:	OEP Parent LLC
		as its general partner
		By:		/s/ Colin M. Farmer
		Name: Colin M. Farmer
		Title: Managing Director
OEP Parent LLC
	By:		/s/ Colin M. Farmer
	Name: Colin M. Farmer
	Title: Managing Director
Dated April 13, 2012

 

9

 

Schedule I

 

The names and titles of the executive officers of OEPX, LLC and their present principal occupations and residence or business addresses are set forth below.  Each occupation set forth opposite an individual’s name refers to OEPX, LLC and each individual is a United States citizen.

 

Name		Position		Address
Colin M. Farmer*		President		One Equity Partners LLC 320 Park Ave, 18th Floor Between 50th and 51st New York, NY 10022
Bradley J. Coppens*		Vice President, Treasurer and Secretary		One Equity Partners LLC 320 Park Ave, 18th Floor Between 50th and 51st New York, NY 10022

 

* Each of Colin M. Farmer and Bradley J. Coppens holds 5,589 shares of restricted common stock and options to acquire 200,936 shares in connection with their service on the Issuer’s Board, and such shares are held for the benefit of One Equity Partners III, L.P.

 

The names of the directors and the names and titles of the executive officers of OEP Parent LLC and their present principal occupations and residence or business addresses are set forth below.  Each occupation set forth opposite an individual’s name refers to OEP Holding Corporation and each individual is a United States citizen.

 

Name		Position		Address
Richard M. Cashin		President and Manager		320 Park Avenue, New York, NY 10022
Christian P. Ahrens		Managing Director		320 Park Avenue, New York, NY 10022
Gregory A. Belinfanti		Managing Director		320 Park Avenue, New York, NY 10022
Henry H. Briance		Managing Director		320 Park Avenue, New York, NY 10022
Kenneth C. Brown		Managing Director		8 Connaught Road, Central, Floor 20 Hong Kong, Hong Kong
James B. Cherry		Managing Director		21 South Clark Street, Chicago, IL 60603-2003
Bradley J. Coppens		Managing Director		320 Park Avenue, New York, NY 10022
Raphael de Balmann		Managing Director		320 Park Avenue, New York, NY 10022
Andrew G. Dunn		Managing Director		320 Park Avenue, New York, NY 10022
Colin M. Farmer		Managing Director		320 Park Avenue, New York, NY 10022

 

10

 

 

Timothy J. Gollin		Managing Director		320 Park Avenue, New York, NY 10022
David Han		Managing Director		320 Park Avenue, New York, NY 10022
Joseph Huffsmith		Managing Director		320 Park Avenue, New York, NY 10022
Thomas J. Kichler		Managing Director		21 South Clark Street, Chicago, IL 60603-2003
James W. Koven		Managing Director		320 Park Avenue, New York, NY 10022
Joseph G. Michels		Managing Director		320 Park Avenue, New York, NY 10022
David Robakidze		Managing Director		320 Park Avenue, New York, NY 10022
Richard W. Smith		Manager		320 Park Avenue, New York, NY 10022
David A. Walsh		Managing Director		320 Park Avenue, New York, NY 10022
William H. Wangerin		Managing Director		21 South Clark Street, Chicago, IL 60603-2003
Erin E. Hill		Chief Financial Officer & Treasurer		320 Park Avenue, New York, NY 10022
Judah A. Shechter		General Counsel & Secretary		277 Park Avenue, New York, NY 10017
Jessica R. Marion		Vice President		10 South Dearborn, Chicago IL 60603-2203
Colleen A. Hartung		Vice President		10 South Dearborn, Chicago IL 60603-2203
Elizabeth De Guzman		Vice President & Assistant Secretary		277 Park Avenue, New York, NY 10017
Ina R. Drew		Manager		270 Park Avenue, New York, NY 10017
Jay Mandelbaum		Manager		270 Park Avenue, New York, NY 10017
Heidi G. Miller		Manager		270 Park Avenue, New York, NY 10017
Christopher von Hugo		Manager		Taunusanlage 21, Frankfurt Germany
James S. Rubin		Manager		320 Park Avenue, New York, NY 10022

 

11

 

The names of the directors and the names and titles of the executive officers of OEP Holding Corporation and their present principal occupations and residence or business addresses are set forth below.  Each occupation set forth opposite an individual’s name refers to Bank One Investment Corporation and each individual is a United States citizen.

 

Name		Position		Address
Richard M. Cashin		President and Director		320 Park Avenue, New York, NY 10022
Christian P. Ahrens		Managing Director		320 Park Avenue, New York, NY 10022
Gregory A. Belinfanti		Managing Director		320 Park Avenue, New York, NY 10022
Henry H. Briance		Managing Director		320 Park Avenue, New York, NY 10022
Kenneth C. Brown		Managing Director		8 Connaught Road, Central, Floor 20 Hong Kong, Hong Kong
James B. Cherry		Managing Director		21 South Clark Street, Chicago, IL 60603-2003
Bradley J. Coppens		Managing Director		320 Park Avenue, New York, NY 10022
Raphael de Balmann		Managing Director		320 Park Avenue, New York, NY 10022
Andrew G. Dunn		Managing Director		320 Park Avenue, New York, NY 10022
Colin M. Farmer		Managing Director		320 Park Avenue, New York, NY 10022
Timothy J. Gollin		Managing Director		320 Park Avenue, New York, NY 10022
David Han		Managing Director		320 Park Avenue, New York, NY 10022
Joseph Huffsmith		Managing Director		320 Park Avenue, New York, NY 10022
Thomas J. Kichler		Managing Director		21 South Clark Street, Chicago, IL 60603-2003
James W. Koven		Managing Director		320 Park Avenue, New York, NY 10022
Joseph G. Michels		Managing Director		320 Park Avenue, New York, NY 10022
David Robakidze		Managing Director		320 Park Avenue, New York, NY 10022
Richard W. Smith		Managing Director and Director		320 Park Avenue, New York, NY 10022
David A. Walsh		Managing Director		320 Park Avenue, New York, NY 10022
William H. Wangerin		Managing Director		21 South Clark Street, Chicago, IL 60603-2003
Erin E. Hill		Chief Financial Officer & Treasurer		320 Park Avenue, New York, NY 10022
Judah A. Shechter		General Counsel & Secretary		277 Park Avenue, New York, NY 10017
Jessica R. Marion		Vice President		10 South Dearborn, Chicago IL 60603-

 

12

 

				2203
Colleen A. Hartung		Vice President		10 South Dearborn, Chicago IL 60603-2203
Elizabeth De Guzman		Vice President & Assistant Secretary		277 Park Avenue, New York, NY 10017
Ina R. Drew		Director		270 Park Avenue, 9th Fl, New York, NY 10017
Jay, Mandelbaum		Director		270 Park Avenue, 9th Fl, New York, NY 10017
Heidi G. Miller		Director		270 Park Avenue , 9th Fl, New York, NY 10017
Jacques, Nasser		Director		100 Bloomfield Hills Pkwy, 1st Fl, BloomfieldHIlls, MI 48304
James S. Rubin		Director		320 Park Avenue, 18th Fl, New York, NY 10022
Von Hugo, Christopher		Director		Taunusanlage 21/05, Frankfurt

 

The names of the directors and the names and titles of the executive officers of JPMorgan Capital Corporation and their present principal occupations and residence or business addresses are set forth below.  Each occupation set forth opposite an individual’s name refers to JPMorgan Capital Corporation and each individual is a United States citizen.

 

Name		Position		Address
Ellen J. Manola		Director		10 South Dearborn, Chicago IL 60603-2203
Francisco J. Pereiro		Director		10 South Dearborn, Chicago IL 60603-2203
Peter G. Weiland		Director		270 Park Avenue, New York, NY 10017
Scott Abramson		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Richard D. Archer		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Christine N. Bannerman		Vice President & Assistant Secretary		4 Chase Metrotech, Brooklyn, NY 11245
Geoffrey P. Bratton		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
Michael S. Bryant		Associate		10 South Dearborn, Chicago, IL 60603-

 

13

 

				2203
Browne, Brigid		Vice President		10 South Dearborn, Chicago IL 60603-2203
Mit C. Buchanan		Managing Director		10 South Dearborn, Chicago IL 60603-2203
William R. Crissy		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Cynthia Cain		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Ana E. Conforti		Vice President		10 South Dearborn, Chicago IL 60603-2203
Richard S. Crowley		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Victoria B. Dal Santo		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Sheila K Delaney		Associate		10 South Dearborn, Chicago, IL 60603-2203
Anand Dandapani		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Jason T. Dinneen		Vice President		10 South Dearborn, Chicago IL 60603-2203
Hellen Doo		Vice President & Asst Secretary		245 Park Avenue, New York, NY 10167-0001
Antonina Doria		Vice President		10 South Dearborn, Chicago IL 60603-2203
Mary K. Duff		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
James A. Durham		Vice President		10 South Dearborn, Chicago IL 60603-2203
Sean M. Dwyer		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
John M. Eber		Managing Director		10 South Dearborn, Chicago IL 60603-2203
James M. Eligator		Managing Director		10 South Dearborn, Chicago IL 60603-2203
Mary Eymard		Vice President		451 Florida Street, Baton Rouge, LA 70801-1700
Jean Fanning		Vice President		10 South Dearborn, Chicago IL 60603-2203

 

14

 

Frieda B. Feiger		Associate		10 South Dearborn, Chicago IL 60603-2203
Linda L. Fernandez		Associate		10 South Dearborn, Chicago IL 60603-2203
James A. Fox		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Emily M. Garrett		Vice President		383 Madison Avenue, New York, NY 10179
Brett A. Geiger		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Heather Glover		Vice President		10 South Dearborn, Chicago IL 60603-2203
Brian R. Gnolfo		Vice President		10 South Dearborn, Chicago IL 60603-2203
Darlene T. Golly		Associate		10 South Dearborn, Chicago IL 60603-2203
Amber Haley		Vice President		10 South Dearborn, Chicago IL 60603-2203
Patricia T. Habicht		Assistant Secretary		10 South Dearborn, Chicago IL 60603-2203
Eric J. Hamm		Vice President		10 South Dearborn, Chicago IL 60603-2203
Munir J. Hasan		Vice President		10 South Dearborn, Chicago IL 60603-2203
Elizabeth M. Hayes		Associate		10 South Dearborn, Chicago IL 60603-2203
Michael D. Heine		Vice President		10 South Dearborn, Chicago IL 60603-2203
Yale C. Henderson		Managing Director		10 South Dearborn, Chicago IL 60603-2203
Jeffrey L. Hinds		Executive Director (Officer)		10 South Dearborn, Chicago IL 60603-2203
Philipp A. Hirche		Vice President		10 South Dearborn, Chicago IL 60603-2203
Anthony J. Horan		Senior Vice President & Assistant Secretary		277 Park Avenue, New York, NY 10172
Rondella Hunt		Vice President		10 South Dearborn, Chicago IL 60603-2203
John T. Hunter		Vice President		10 South Dearborn, Chicago IL 60603-2203

 

15

 

Steven N. Ignelzi		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
Michelle L. Jones		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Suzanne M. Jones		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
Min Yun Kim		Associate		10 South Dearborn, Chicago, IL 60603-2203
Jan I. Krueger		Associate		10 South Dearborn, Chicago, IL 60603-2203
William P. Kusack Jr		Managing Director		10 South Dearborn, Chicago, IL 60603-2203
Elisa A. Lass		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
Lennox Leighton		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Mark Lenhardt		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Melvina E. Lloyd		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Kurt Lundgren		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Ellen J. Manola		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
Ellen J. Manola		Treasurer		10 South Dearborn, Chicago, IL 60603-2203
Kin, Ryan		Vice President		10 South Dearborn Chicago, IL 60603-2203
Douglas, S. Lloyd		Executive Director (Officer)		10 South Dearborn Chicago, IL 60603-2203
Marie Y. Martinez		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Mark J. McCann		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
Colleen A. Meade		Executive Director (Officer) Secretary		4 Chase Metrotech Center, Brooklyn, NY 11245-0001
Allison Metzger		Vice President		10 South Dearborn, Chicago, IL 60603-2203
D. C. Robinson		Executive Director		10 South Dearborn Chicago, IL 60603-2203

 

16

 

Deanna C. Mueller		Associate		10 South Dearborn, Chicago, IL 60603-2203
Patrick J. Nash		Managing Director		10 South Dearborn, Chicago, IL 60603-2203
Timothy P. O’Keefe		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Susan M. Ochoa		Associate		10 South Dearborn, Chicago, IL 60603-2203
Gina I. Orlando		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Jon W. Pagac		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Melanie A. Pagliari		Associate		10 South Dearborn, Chicago, IL 60603-2203
Susan Parsons		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Anne F. Pax		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
William C. Pelletier		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203
Bonnie L. Percy-Hill		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Francisco J. Pereiro		Chairman		10 South Dearborn, Chicago, IL 60603-2203
Francisco J. Pereiro		President		10 South Dearborn, Chicago, IL 60603-2203
Brian Polt		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Jeremy S. Reinhard		Vice President		10 South Dearborn, Chicago, IL 60603-2203
Paulius Remeza		Associate		10 South Dearborn, Chicago, IL 60603-2203
D. C. Robinson		Executive Director (Officer)		10 South Dearborn, Chicago, IL 60603-2203

 

17

 

Mary F. Sackley		Vice President		10 South Dearborn, Chicago IL, 60603-2203
John P. Scothorn		Vice President		10 South Dearborn, Chicago IL, 60603-2203
Shahani, Hasmita		Associate		10 South Dearborn Chicago, IL, 60603-2203
Socheat V. Som		Vice President		10 South Dearborn, Chicago IL, 60603-2203
Rubiao Song		Executive Director (Officer)		383 Madison Avenue, New York, NY 10179
Joel P. Spenadel		Executive Director (Officer)		10 South Dearborn, Chicago IL, 60603-2203
Jeffrey S. Steenwyk		Vice President		10 South Dearborn, Chicago IL, 60603-2203
Theodora Stojka		Vice President		10 South Dearborn, Chicago IL, 60603-2203
Aloysius T. Stonitsch		Managing Director		10 South Dearborn, Chicago IL, 60603-2203
David R. Stoppel		Associate		10 South Dearborn, Chicago IL, 60603-2203
Patricia L. Striegel		Associate		10 South Dearborn, Chicago IL, 60603-2203
Galina Tam		Associate		10 South Dearborn, Chicago IL, 60603-2203
Eric T. White		Executive Director (Officer)		10 South Dearborn Chicago, IL, 60603-2203
Cynthia A. Vanina		Executive Director (Officer)		10 South Dearborn, Chicago IL, 60603-2203
Damian Warshall		Vice President		10 South Dearborn, Chicago IL, 60603-2203
Krystal Zec		Vice President		10 South Dearborn, Chicago IL, 60603-2203
Jon D. Zywiciel		Vice President		10 South Dearborn, Chicago IL, 60603-2203

 

18

 

The names and titles of the executive officers of Banc One Financial LLC and their present principal occupations and residence or business addresses are set forth below.  Each occupation set forth opposite an individual’s name refers to Banc One Financial LLC and each individual is a United States citizen.

 

Name		Position		Address
James Dimon		President, Chief Executive Officer and Chairman of the Board of Directors		270 Park Avenue, New York, NY 10017
Frank Bisignano		Chief Administrative Officer		270 Park Avenue, New York, NY 10017
Douglas L. Braunstein		Chief Financial Officer		270 Park Avenue, New York, NY 10017
Steven D. Black		Co-Chief Executive Officer Investment Bank		270 Park Avenue, New York, NY 10017
Michael J. Cavanagh		Chief Financial Officer and Director		270 Park Avenue, New York, NY 10017
John L. Donnelly		Director of Human Resources		270 Park Avenue, New York, NY 10017
Ina R. Drew		Chief Investment Officer		270 Park Avenue, New York, NY 10017
Samuel Todd Maclin		Chief Executive Officer of Consumer and Business		270 Park Avenue, New York, NY 10017
David C. Novak		Director		270 Park Avenue New York, NY 10017
Jay Mandelbaum		Head Strategy and Business Development		270 Park Avenue, New York, NY 10017
Douglas B. Petno		Chief Executive Officer of Commerical Banking		270 Park Avenue, New York, NY 10017
Charles W. Scharf		Head Retail Financial Services		270 Park Avenue, New York, NY 10017
Gordon A. Smith		Chief Executive Officer Card Services		270 Park Avenue, New York, NY 10017
James E. Staley		Chief Executive Officer of Asset Management		270 Park Avenue, New York, NY 10017
Stephen M. Cutler		General Counsel		270 Park Avenue, New York, NY 10017
Barry L. Zubrow		Head of Corporate		270 Park Avenue, New York, NY 10017

 

19

 

		Regulatory Affairs		10017
Crandall C. Bowles		Director		Springs Global US Inc. 205 N White Street Fort Mill, SC 29715-1654
Stephen B. Burke		Director		Comcast Cable Communications Inc. 1500 Market Philadelphia, PA 19102
James S. Crown		Director		Henry Crown and Company 222 N. LaSalle Street, Suite 2000 Chicago, IL 60601
David M. Cote		Director		Honeywell International Inc. 101 Columbia Rd. Morristown, NJ 07962-1219
Ellen V. Futter		Director		American Museum of Natural History Central Park West at 79th Street New York, NY 10024-5192
William H. Gray III		Director		The College Fund/UNCF 8260 Willow Oaks Corporate Drive PO Box 10444 Fairfax, VA 22031-8044
Laban P. Jackson Jr.		Director		Clear Creek Properties 2365 Harrodsburg Rd. Suite B230 Lexington, KY 40504
David C. Novak		Director		Yum! Brands Inc. 1441 Gardiner Lane Louisville, KY 40213
William C. Weldon		Director		270 Park Avenue New York, NY 10017

 

20

Exhibit 10

 

EXECUTION VERSION

 

TENDER AND SUPPORT AGREEMENT

 

This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of April 10, 2012, is by and among Danaher Corporation, a Delaware corporation (“Parent”), Termessos Acquisition Corp., a Michigan corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and each of the entities set forth on Schedule A hereto (each, a “Shareholder”).

 

WHEREAS, as of the date hereof, each Shareholder is the record and beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of the number of shares of common stock, par value $0.10 per share (“Common Stock”), of X-Rite, Incorporated, a Michigan corporation (the “Company”), set forth opposite such Shareholder’s name on Schedule A (all such shares set forth on Schedule A, together with any shares deemed Subject Shares pursuant to the terms of Section 4.6 hereof being referred to herein as the “Subject Shares”; provided that the term “Subject Shares” shall not include any other shares of Common Stock held by any such Shareholder which are not listed on Schedule A (or not deemed Subject Shares pursuant to Section 4.6));

 

WHEREAS, Parent, Merger Sub and the Company have simultaneously entered into an Agreement and Plan of Merger, dated as of the date hereof and as it may be amended from time to time (the “Merger Agreement”), which provides, among other things, for Merger Sub to commence a tender offer for all of the issued and outstanding Common Stock of the Company (the “Offer”) and the merger of the Company and Merger Sub (the “Merger”), upon the terms and subject to the conditions set forth in the Merger Agreement (capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement);

 

WHEREAS, each Shareholder is supportive of the Merger Agreement and the transactions contemplated thereby and has informed Parent that it intends to tender in the Offer all shares of Company Common Stock held by such Shareholder (or its Affiliates) and, if applicable, vote or cause to be voted all such shares of Company Common Stock in favor of the approval and adoption of the Merger Agreement and the transactions contemplated thereunder; and

 

WHEREAS, as a condition to their willingness to enter into the Merger Agreement, Parent and Merger Sub have required that each Shareholder, and as an inducement and in consideration therefor, each Shareholder (in such Shareholder’s capacity as a holder of the Subject Shares) has agreed to, enter into this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby agree as follows:

 

 

ARTICLE I
AGREEMENT TO TENDER

 

1.1          Agreement to Tender.  Each Shareholder agrees to validly tender or instruct such Shareholder’s broker or such other person that is the holder of record of such Shareholder’s Subject Shares to tender in the Offer all of such Shareholder’s Subject Shares pursuant to and in accordance with the terms of the Offer, free and clear of all Encumbrances (other than Permitted Encumbrances).  Without limiting the generality of the foregoing, as promptly as practicable after, but in no event later than ten (10) Business Days after, the commencement of the Offer (or, if a Shareholder has not received the Offer Documents by such time, within two (2) Business Days following receipt of such documents but in any event prior to the Expiration Date), each Shareholder shall: (i) deliver pursuant to the terms of the Offer (A) a letter of transmittal with respect to such Shareholder’s Subject Shares complying with the terms of the Offer, (B) a Certificate representing such Subject Shares or an “agent’s message” (or such other evidence, if any, of transfer as the Paying Agent may reasonably request) in the case of a book-entry share of any uncertificated Subject Shares and (C) all other documents or instruments required to be delivered by other shareholders of the Company pursuant to the terms of the Offer; or (ii) instruct such Shareholder’s broker or such other person (as such term is defined in the Merger Agreement) that is the holder of record of any Subject Shares beneficially owned by such Shareholder to tender such Subject Shares pursuant to and in accordance with clause (i) of this Section 1.1 and the terms of the Offer.  Each Shareholder agrees that, once such Shareholder’s Subject Shares are tendered, such Shareholder will not withdraw any of such Subject Shares from the Offer unless and until (A) the Offer shall have been terminated in accordance with the terms of the Merger Agreement or (B) this Agreement shall have been terminated in accordance with its terms.

 

1.2          Return of Subject Shares.  If the Offer is terminated or withdrawn, or the Merger Agreement is terminated prior to the purchase of the Subject Shares in the Offer or if this Agreement is otherwise terminated in accordance with the terms hereof, Parent and Merger Sub shall promptly return, and shall cause any depository acting on behalf of Parent and Merger Sub to return, all Subject Shares (and any other Shares) tendered by any Shareholder in the Offer to such Shareholder.

 

ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS

 

Each Shareholder represents and warrants to Parent and Merger Sub as to such Shareholder, severally and not jointly, that:

 

2.1          Authorization; Binding Agreement.  Such Shareholder is duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated or constituted and the consummation of the transactions contemplated hereby are within such Shareholder’s corporate or organizational powers and have been duly authorized by all necessary corporate or organizational actions on the part of such Shareholder.  Such Shareholder has full corporate or organizational power and authority to execute, deliver and perform this Agreement.  This Agreement has been duly and validly executed and delivered by such Shareholder, and constitutes a legal, valid and binding obligation of such Shareholder enforceable against such

 

2

 

Shareholder in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally and general equitable principles (whether considered in a proceeding in equity or at law).

 

2.2          Non-Contravention.  The execution and delivery of this Agreement by such Shareholder does not, and the performance by such Shareholder of such Shareholder’s obligations hereunder and the consummation by such Shareholder of the transactions contemplated hereby will not, (i) violate any Laws applicable to such Shareholder or such Shareholder’s Subject Shares, (ii) except as may be required by the Exchange Act or the Securities Act or other applicable securities Laws, require any consent, approval, order, authorization or other action by, or filing with or notice to, any person (including any Governmental Entity) under, constitute a default (with or without the giving of notice or the lapse of time or both) under, or give rise to any right of termination, cancellation or acceleration under, or result in the creation of any Encumbrances (other than Permitted Encumbrances) on any of the Subject Shares pursuant to, any Contract, trust, commitment, order or other instrument binding on such Shareholder or any applicable Law or (iii) violate any provision of such Shareholder’s organizational documents, except, in the case of each of (i), (ii) and (iii), for matters that, individually or in the aggregate, would not reasonably be expected to prevent or materially delay or impair the consummation by such Shareholder of the transactions contemplated by this Agreement or otherwise adversely impact such Shareholder’s ability to perform its obligations hereunder in any material respect.

 

2.3          Ownership of Subject Shares.  Such Shareholder is the record or beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of such Shareholder’s Subject Shares and has good and marketable title to such Subject Shares free and clear of any Liens, claims, proxies, voting trusts or agreements, options, rights, understandings or arrangements or any other encumbrances or restrictions whatsoever on title, transfer or exercise of any rights of a Shareholder in respect of such Subject Shares (collectively, “Encumbrances”), except as (i) provided hereunder, (ii) provided in any Key Stockholder Agreement and (iii) pursuant to any applicable restrictions on transfer under the Securities Act (collectively, “Permitted Encumbrances”).  Except pursuant to this Agreement, no person has any contractual or other right or obligation to purchase or otherwise acquire any of such Shareholder’s Subject Shares.

 

2.4          Voting Power.  Subject to the terms of any Key Stockholder Agreement, such Shareholder has full voting power, with respect to such Shareholder’s Subject Shares, and full power of disposition, full power to issue instructions with respect to the matters set forth herein and full power to agree to all of the matters set forth in this Agreement, in each case with respect to all of such Shareholder’s Subject Shares.  Subject to the terms of any Key Stockholder Agreement, none of such Shareholder’s Subject Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such Subject Shares, except as provided hereunder.

 

2.5          Reliance.  Such Shareholder has had the opportunity to review the Merger Agreement and this Agreement with counsel of such Shareholder’s own choosing.  Such Shareholder understands and acknowledges that Parent and Merger Sub are entering into the

 

3

 

Merger Agreement in reliance upon such Shareholder’s execution, delivery and performance of this Agreement.

 

2.6          Absence of Litigation.  With respect to such Shareholder, as of the date hereof, there is no Action, suit, investigation or proceeding pending against, or, to the knowledge of such Shareholder, threatened in writing against such Shareholder or any of such Shareholder’s properties or assets (including the Subject Shares) that would reasonably be expected to prevent, materially delay or impair the consummation by such Shareholder of the transactions contemplated by this Agreement or otherwise adversely impact such Shareholder’s ability to perform its obligations hereunder in any material respect.

 

2.7          Brokers.  No broker, finder, financial advisor, investment banker or other person is entitled to any brokerage, finder’s, financial advisor’s or other similar fee or commission in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of such Shareholder for which Parent, Merger Sub, the Company, the Surviving Corporation or any of their respective Affiliates would have any liability (provided that this Section 2.7 shall not apply to fees payable to Centerview with respect to the Merger Agreement pursuant to the letter agreement between Centerview and the Company, dated November 7, 2011).

 

ARTICLE III
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

 

Each of Parent and Merger Sub represent and warrant to the Shareholders, jointly and severally, that:

 

3.1          Organization; Authorization.  Parent is duly organized, validly existing and in good standing under the laws of the State of Delaware.  Merger Sub is duly organized, validly existing and in good standing under the laws of the State of Michigan.  The consummation of the transactions contemplated hereby are within each of Parent’s and Merger Sub’s corporate powers and have been duly authorized by all necessary corporate actions on the part of Parent and Merger Sub.  Parent and Merger Sub have full corporate power and authority to execute, deliver and perform this Agreement.

 

3.2          Binding Agreement.  This Agreement has been duly authorized, executed and delivered by each of Parent and Merger Sub and constitutes a legal, valid and binding obligation of Parent and Merger Sub enforceable against Parent and Merger Sub in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally and general equitable principles (whether considered in a proceeding in equity or at law).

 

3.3          Non-Contravention.  The execution and delivery of this Agreement by each of Parent and Merger Sub does not, and the performance by Parent and Merger Sub of its respective obligations hereunder and the consummation by Parent and Merger Sub of the transactions contemplated hereby will not, (i) violate any Laws applicable to Parent or Merger Sub or any of their respective properties is or may be bound or (ii) violate any provision of Parent’s or Merger Sub’s organizational documents, except, in the case of each of (i) and (ii), for matters that,

 

4

 

individually or in the aggregate, would not reasonably be expected to prevent or materially delay or impair the consummation by Parent or Merger Sub of the transactions contemplated by this Agreement or otherwise adversely impact Parent’s or Merger Sub’s ability to perform its obligations hereunder in any material respect.

 

ARTICLE IV
ADDITIONAL COVENANTS OF THE SHAREHOLDERS

 

Each Shareholder hereby covenants and agrees, severally and not jointly, that until the termination of this Agreement:

 

4.1          Voting of Subject Shares. At every meeting of the Company’s Shareholders called, and at every adjournment or postponement thereof, such Shareholder shall, or shall cause the holder of record on any applicable record date to, include such Shareholder’s Subject Shares in any computation for purposes of establishing a quorum at any such meeting of the Company’s Shareholders and vote such Shareholder’s Subject Shares (to the extent that any of the Subject Shares are not purchased in the Offer) (the “Vote Shares”): (i) in favor of (A) approval and adoption of the Merger Agreement and the transactions contemplated thereunder and (B) approval of any proposal to adjourn or postpone the meeting to a later date, if there are not sufficient votes for the approval of the Merger Agreement and the transactions contemplated thereunder on the date on which such meeting of the Company’s Shareholders is held; (ii) against (A) any action or agreement which would in any material respect impede, interfere with or prevent the Offer or the Merger, including, but not limited to, any other extraordinary corporate transaction, including a merger, acquisition, sale, consolidation, reorganization, recapitalization, extraordinary dividend or liquidation involving the Company and any Person (other than Parent, Merger Sub or their Affiliates), or any other proposal of any Person (other than Parent, Merger Sub or their Affiliates) to acquire the Company or all or substantially all of the assets thereof, (B) any Alternative Proposal or (C) any action, proposal, transaction or agreement that would reasonably be expected to result in the occurrence of any condition set forth in Annex I to the Merger Agreement or result in a breach of any covenant, representation or warranty or any other obligation or agreement of such Shareholder under this Agreement (including any proposal to change in any manner the voting rights of the Subject Shares); and/or (iii) in favor of any other matter necessary for consummation of the transactions contemplated by the Merger Agreement, which is considered at any such meeting of the Company’s Shareholders.

 

4.2          No Transfer; No Inconsistent Arrangements.  Except as provided hereunder (including pursuant to Section 1.1 or Section 4.1) or under the Merger Agreement, such Shareholder shall not, directly or indirectly, (i) create or permit to exist any Encumbrance, other than Permitted Encumbrances, on any such Subject Shares, (ii) transfer, sell, assign, gift, hedge, pledge or otherwise dispose (whether by sale, liquidation, dissolution, dividend or distribution) of, or enter into any derivative arrangement with respect to (collectively, “Transfer”), any or all of such Shareholder’s shares of Common Stock or any right or interest therein (or consent to any of the foregoing), (iii) enter into any contract, option or other agreement, arrangement or understanding with respect to any Transfer of such Subject Shares or any interest therein, (iv) grant or permit the grant of any proxy, power-of-attorney or other authorization or consent in or with respect to any such Subject Shares, (v) deposit or permit the deposit of any of such Shareholder’s Subject Shares into a voting trust or enter into a voting agreement or arrangement

 

5

 

with respect to any Subject Shares, or (vi) take or permit any other action that would in any way restrict, limit or interfere with the performance of such Shareholder’s obligations hereunder or the transactions contemplated hereby or otherwise make any representation or warranty of such Shareholder herein untrue or incorrect in any material respect.  Any action taken in violation of the foregoing sentence shall be null and void ab initio and such Shareholder agrees that any such prohibited action may and should be enjoined.  If any involuntary Transfer of any of the Subject Shares shall occur (including, but not limited to, a sale by such Shareholder’s trustee in any bankruptcy, or a sale to a purchaser at any creditor’s or court sale), the transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Subject Shares subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect until valid termination of this Agreement.  Such Shareholder agrees that it shall not, and shall cause each of its Affiliates not to, become a member of a “group” (as defined under Section 13(d) of the Exchange Act) with respect to any equity interests in the Company for the purpose of opposing or competing with or taking any actions inconsistent with the transactions contemplated by the Merger Agreement.  Notwithstanding the foregoing, such Shareholder may make Transfers of such Shareholder’s Shares or any right or interest therein and any other shares of common stock held by such Shareholder (a) to any wholly-owned Subsidiary of such Shareholder or any Affiliate of such Shareholder, in which case any Subject Shares so Transferred shall continue to be bound by this Agreement and provided that any such transferee agrees in writing to be bound by the terms and conditions of this Agreement prior to the consummation of, and as a condition to, any such Transfer; or (b) as Parent may otherwise agree in writing in its sole discretion.

 

4.3          Actions.  Such Shareholder agrees not to commence or join in, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, Merger Sub, the Company or any of their respective successors (x) challenging the validity of, or seeking to enjoin the operation of, any provision of this Agreement or (y) alleging breach of any fiduciary duty of any person in connection with the negotiation and entry into the Merger Agreement.

 

4.4          Documentation and Information.  Except as required by applicable Law (including, without limitation the filing of a Schedule 13D with the SEC, or an amendment of a previously filed Schedule 13D, which may include this Agreement as an exhibit thereto), such Shareholder shall not make any public announcement regarding this Agreement, the Merger Agreement, the Offer and the other transactions contemplated hereby and thereby without the prior written consent of Parent, such consent not to be unreasonably withheld or delayed. Such Shareholder hereby authorizes Parent and Merger Sub to publish and disclose in all documents and schedules filed with the SEC, and any press release or other disclosure document that Parent or Merger Sub reasonably determines to be necessary in connection with the Offer, the Merger and any transactions contemplated by the Merger Agreement, such Shareholder’s identity and ownership of the Subject Shares, the existence of this Agreement and the nature of such Shareholder’s commitments and obligations under this Agreement, and such Shareholder acknowledges that Parent and Merger Sub may in Parent’s sole discretion, file this Agreement or a form hereof with the SEC or any other Governmental Entity.

 

4.5          No Solicitation.  Such Shareholder shall not, nor shall it authorize or permit any of its Representatives to, directly or indirectly, (i) initiate, solicit, propose, knowingly encourage

 

6

 

(including by providing information) or knowingly facilitate the making of any proposal or offer that constitutes, or could reasonably be expected to lead to, an Alternative Proposal, (ii) enter into any agreement with respect to any Alternative Proposal, (iii) engage in, continue or otherwise participate in any discussions or negotiations regarding, or provide any information or data concerning the Company or any of its Subsidiaries to any person relating to, any Alternative Proposal or any proposal or offer that could reasonably be expected to lead to an Alternative Proposal or (iv) tender any Subject Shares in connection with an Alternative Proposal.  Such Shareholder shall, and shall cause its Representatives to, immediately cease all discussions and negotiations with any person that may be ongoing with respect to any proposal that constitutes, or is reasonably expected to lead to, any Alternative Proposal.

 

4.6          Adjustments.  In the event of any stock split, stock dividend, merger, reorganization, recapitalization, reclassification, combination, exchange of shares or the like of the capital stock of the Company on, of or affecting the Subject Shares, then the terms of this Agreement shall apply to the shares of Company Common Stock received in respect of the Subject Shares by such Shareholder immediately following the effectiveness of the events described in this Section 4.6, as though they were Subject Shares hereunder.

 

4.7          Key Stockholder Agreements.  Prior to the Acceptance Time, each Shareholder shall enter into irrevocable agreements to terminate the Key Stockholder Agreements, which termination shall be conditioned solely upon the occurrence of the Closing, and each Shareholder shall make available to Parent a complete and correct copy of such agreements to terminate the Key Stockholder Agreements.

 

ARTICLE V
MISCELLANEOUS

 

5.1          Notices.  Any notices or other communications required or permitted under, or otherwise in connection with this Agreement, shall be in writing and shall be deemed to have been duly given when delivered in person, or upon confirmation of receipt when transmitted by facsimile transmission or by electronic mail, or on receipt after dispatch by registered or certified mail, postage prepaid, or on the next Business Day if transmitted by national overnight courier, in each case addressed as follows: (i) if to Parent or Merger Sub, in accordance with the provisions of the Merger Agreement and (ii) if to a Shareholder, to such Shareholder’s address, facsimile number or e-mail address set forth on Schedule A hereto, or to such other address, facsimile number or e-mail address as such party may hereafter specify for the purpose by notice to each other party hereto.

 

5.2          Termination.  This Agreement shall terminate automatically, without any notice or other action by any person, upon the first to occur of (i)  the termination of the Merger Agreement in accordance with its terms, (ii) the Effective Time, (iii) the Offer shall have terminated or the Expiration Date shall have occurred, in each case without acceptance for payment of the Subject Shares pursuant to the Offer, (iv) the date of any material modification, waiver or amendment to any provision of the Merger Agreement or the terms of the Offer that reduces the amount, changes the form or otherwise adversely affects the consideration payable to the Shareholders pursuant to the Merger Agreement as in effect on the date hereof (subject to adjustments in compliance with Section 3.2(h) of the Merger Agreement), (v) any amendment,

 

7

 

modification or waiver of the Minimum Condition such that Parent or Merger Sub would beneficially own less a majority of the of the Shares then outstanding on a fully diluted basis (including as outstanding only options that are vested as of that date or that may vest prior to the End Date, if any, including as a result of the transactions contemplated by the Merger Agreement) after giving effect to the consummation of the Offer and (vi) the mutual written consent of all of the parties hereto.  Upon termination of this Agreement, no party shall have any further obligations or liabilities under this Agreement; provided, however, that (x) nothing set forth in this Section 5.2 shall relieve any party from liability for any breach of this Agreement prior to termination hereof and (y) the provisions of this Article V shall survive any termination of this Agreement.

 

5.3          Amendments and Waivers.  Any provision of this Agreement may be amended or waived if such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement or, in the case of a waiver, by each party against whom the waiver is to be effective.  No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The Parent and Merger Sub shall not waive or amend any provision of any other Tender and Support Agreement, dated as of the date hereof, by and between the Parent and Merger Sub and any other shareholder of the Company in a manner which is more favorable to such shareholder unless an equivalent amendment or waiver is offered to the Shareholder for its approval under this Agreement.

 

5.4          Expenses.  All costs and expenses incurred in connection with this Agreement shall be paid by the party incurring such cost or expense.

 

5.5          Binding Effect; Benefit; Assignment.  The parties hereby agree that their respective representations, warranties and covenants set forth herein are solely for the benefit of the other parties, in accordance with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer upon any person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein, except to the extent that such rights, interests or obligations are assigned pursuant to a Transfer permitted under Section 4.2.  Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties (whether by operation of Law or otherwise) in violation of this Agreement without the prior written consent of the other parties.  No assignment by any party shall relieve such party of any of its obligations hereunder.  Subject to the foregoing, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and permitted assigns.

 

5.6          Governing Law; Venue.  (a) This Agreement and all claims or causes of action (whether in contract, tort or otherwise) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement), shall be construed, performed and enforced in accordance with the Laws of the State of Delaware without giving effect to its principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of the Laws of another jurisdiction.  Any Action against,

 

8

 

arising out of or relating to this Agreement or the transactions contemplated hereby shall be brought solely and exclusively in the courts of the State of Delaware, or in any direct appellate court therefrom; provided that if (and only after) such courts determine that they lack subject matter jurisdiction over any such legal Action, such legal Action shall be brought solely and exclusively in the Federal courts of the United States located in the State of Delaware, or in any direct appellate court therefrom.  Each of the parties hereto agrees that a final judgment (subject to any appeals therefrom) in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.  Each party hereby irrevocably submits to the exclusive jurisdiction of such courts in respect of any legal Action arising out of or relating to this Agreement or the transactions contemplated hereby or thereby, and hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any Action arising out of or relating to this Agreement or the transactions contemplated hereby in any such court in accordance with the provisions of this Section 5.6.  Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.  Each of the parties hereto hereby irrevocably and unconditionally consents to service of process in the manner provided for notices in Section 5.1.  Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by law.

 

(b)           EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.  EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 5.6(b).

 

5.7          Counterparts; Delivery by Facsimile or Email.  This Agreement may be executed by facsimile and in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.  This Agreement, and any amendments hereto, waivers hereof or consents or notifications hereunder, to the extent signed and delivered by means of a facsimile machine or by email with facsimile or scan attachment, shall be treated in all manner and respects as an original contract and shall be considered to have the same binding legal effects as if it were the original signed version thereof delivered in person.  At the request of any party, each other party shall re-execute original forms thereof and deliver them to all other parties.  No party shall raise the use of a facsimile machine or email to

 

9

 

deliver a signature or the fact that any signature or Contract was transmitted or communicated through the use of facsimile machine or by email with facsimile or scan attachment as a defense to the formation of a contract, and each such party forever waives any such defense.

 

5.8          Entire Agreement.  This Agreement constitutes the entire agreement of the parties and supersedes all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof.  For the avoidance of doubt, any commercial Contracts or Contracts that are not expressly related to the transactions contemplated by this Agreement between Parent or any of its Subsidiaries or Affiliates, on the one hand, and any Shareholder that is a party hereto or any of its Affiliates, on the other hand, shall not be deemed superseded pursuant to the preceding sentence.

 

5.9          Severability.  If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party.  Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the end that transactions contemplated hereby are fulfilled to the greatest extent possible.

 

5.10        Specific Performance.  The parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof, and, accordingly, that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.  In any action for specific performance, the parties will waive the defense of adequacy of a remedy at law, and the parties waive any requirement for the securing or posting of any bond in connection with the remedies referred to in this Section 5.10.

 

5.11        Headings.  The Section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

 

5.12        Mutual Drafting.  Each party has participated in the drafting of this Agreement, which each party acknowledges is the result of extensive negotiations between the parties; accordingly, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement.

 

5.13        Further Assurances.  Parent, Merger Sub and each Shareholder will execute and deliver, or cause to be executed and delivered, all further documents and instruments and use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws and regulations, to perform their respective obligations under this Agreement.

 

10

 

5.14        Interpretation.  Unless the context otherwise requires, as used in this Agreement: (i) “or” is not exclusive; (ii) “including” and its variants mean “including, without limitation” and its variants; (iii) words defined in the singular have the parallel meaning in the plural and vice versa; (iv) words of one gender shall be construed to apply to each gender; and (v) the terms “Article,” “Section” and “Schedule” refer to the specified Article, Section or Schedule of or to this Agreement.

 

5.15        Capacity as Shareholder.  Each Shareholder signs this Agreement solely in such Shareholder’s capacity as a Shareholder of the Company, and not in such Shareholder’s capacity as an officer or director of the Company or any other capacity and this Agreement shall not limit or otherwise affect the actions of such Shareholder or any Affiliate, employee or designee of such Shareholder or any of its Affiliates in its capacity, if applicable, as an officer or director of the Company, including in the exercise of such person’s fiduciary duties as a director or officer of the Company.

 

5.16        No Agreement Until Executed.  This Agreement shall not be effective unless and until (i) the Merger Agreement is executed by all parties thereto and (ii) this Agreement is executed by all parties hereto.

 

5.17        No Ownership Interest.  Except as otherwise provided herein, nothing contained in this Agreement shall be deemed to vest in Parent or Merger Sub any direct or indirect ownership or incidence of ownership of or with respect to the Shares of the Shareholders.  All rights, ownership and economic benefits of and relating to the Shares of the Shareholders shall remain vested in and belong to each applicable Shareholder, and neither Parent nor Merger Sub shall have any authority to manage, direct, restrict, regulate, govern, or administer any of the policies or operations of the Company or exercise any power or authority to direct such Shareholder in the voting of any of the Shares, except as otherwise provided herein.

 

[Signature Page Follows]

 

11

 

The parties are executing this Agreement on the date set forth in the introductory clause.

 

	DANAHER CORPORATION
	By:	/s/ Daniel L. Comas
	Name:	Daniel L. Comas
	Title:	Executive Vice President and Chief Financial Officer
	TERMESSOS ACQUISITION CORP.
	By:	/s/ Daniel L. Comas
	Name:	Daniel L. Comas
	Title:	President and Chief Executive Officer

 

[Signature Page to Tender and Support Agreement]

 

 

	OEPX, LLC
	By:	/s/ Colin M. Farmer
	Name:
	Title:

 

[Signature Page to Tender and Support Agreement]

 

 

Schedule A

 

Name of Shareholder		No. Shares		Notice Information:
OEPX, LLC		19,711,630		c/o One Equity Partners 320 Park Avenue, 18th Floor New York, NY 10022 Tel: 212-277-1500 Facsimile: 212-277-1572 Attention: Colin M. Farmer

 

[Schedule A to Tender and Support Agreement]